Changing concepts of medical treatment of endometriosis
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Studies on the natural history of endometriosis have demonstrated that the majority of endometriosis implants tend to progress, a finding that indicates eradication of the lesions by medical and/or surgical approaches. Infertility and dysmenorrhea are other indications for medical therapy in this disease. In recent prospective and controlled studies, progestin (at high doses), gestrinone and GnRH agonist analogues have been equally effective as regards elimination of endometriosis and relief of endometriosis‐associated symptoms, compared to danazol, a standard treatment in endometriosis. These four classes of drugs differ, however, in their adverse effects and as regards compliance. Danazol is a steroid with androgenic and anabolic effects and it adversely affects lipid metabolism. Gestrinone and 17‐OH progestins are weaker, and GnRH agonist analogues and some progestins neutral in these respects. GnRH agonist analogues induce a hypo‐estrogenic state with associated climacteric symptoms and mineral loss from the bones. The clinical value of combinations of GnRH analogue and steroid(s), used to prevent these side‐effects, is so far unclear. Laparoscopic microsurgery has revolutionized the treatment of endometriosis lesions. Hence, hormone treatment as a supplement to microsurgical approaches may become a dominant form of medical therapy in endometriosis. The definitive value of pre‐ or post‐operative hormonal treatment in this disease should, however, be tested in controlled trials. Such studies have proved antiprostaglandins to be useful in the treatment of dysmenorrhea secondary to endometriosis. Because each of the four drugs was ineffective in the treatment of infertility associated with endometriosis it is a waste of time to expose patients desiring pregnancy to long‐term hormonal therapy. Ovarian hyperstimulation with IVF and other methods of assisted fertilisation are promising alternatives, but their definitive value is so far unproven in this disease. Conclusively, the significance of medical therapy in endometriosis is only partly resolved, and therefore, many therapeutic problems await prospective randomised trials and new innovations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sampson, J. A. (1927) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)30003-x · Cited by 2,334
The Relation of Endometriosis to Menstrual Characteristics, Smoking, and Exercise
Cramer, D. W. (1986) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1986.03370140102032 · Cited by 367
Hormone treatment of endometriosis: The estrogenthreshold hypothesis
Barbieri, R. L. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(92)91706-g · Cited by 335
Dlugi, A. M., Miller, J. D., & Knittle, J. (1990) · Fertility and Sterility · doi:10.1016/s0015-0282(16)53755-8 · Cited by 279
Telimaa, S., Puolakka, J., & Kauppila, A. (1987) · Gynecological Endocrinology · doi:10.3109/09513598709082692 · Cited by 241
Self-citationEndometriosis: its association with retrograde menstruation, dysmenorrhoea and tubal pathology
LIU, D. T. Y., & HITCHCOCK, A. (1986) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1986.tb07995.x · Cited by 230
Deaton, J. L., Gibson, M., Blackmer, K. M., Nakajima, S. T., Badger, G. J., & Brumsted, J. R. (1990) · Fertility and Sterility · doi:10.1016/s0015-0282(16)54009-6 · Cited by 171
Kettel, L. M., Murphy, A. A., Mortola, J. F., Liu, J. H., Ulmann, A., & Yen, S. S. C. (1991) · Fertility and Sterility · doi:10.1016/s0015-0282(16)54531-2 · Cited by 151
Shaw, R. W. (1992) · Fertility and Sterility · doi:10.1016/s0015-0282(16)55205-4 · Cited by 119
Fedele, L., Bianchi, S., Marchini, M., Villa, L., Brioschi, D., & Parazzini, F. (1992) · Fertility and Sterility · doi:10.1016/s0015-0282(16)55132-2 · Cited by 79
Cited by
Aromatase inhibitors: the next generation of therapeutics for endometriosis?
Attar, E., & Bulun, S. E. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.09.064 · Cited by 184
Okada, H. (2001) · Molecular Human Reproduction · doi:10.1093/molehr/7.4.341 · Cited by 104
“Although slight oestrogenic effects of cerebral thrombosis (Barbieri, 1990; Kauppila, 1993).”
Effects of dienogest, a synthetic steroid, on experimental endometriosis in rats
Katsuki, Y., Takano, Y., Futamura, Y., Shibutani, Y., Aoki, D., Udagawa, Y., & Nozawa, S. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1380216 · Cited by 84
Endometriosis: Current management
Lu, P. Y., & Ory, S. J. (1995) · Mayo Clinic Proceedings · doi:10.4065/70.5.453 · Cited by 80
Mei, L., Bao, J., Tang, L., Zhang, C., Wang, H., Sun, L., Ma, G., Huang, L., Yang, J., Zhang, L., et al. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.01.012 · Cited by 36
Metadata
- Authors
- Kauppila, A.
- Venue
- Acta Obstetricia et Gynecologica Scandinavica
- Publisher
- Wiley
- Published
- 1993-07
- Volume
- 72
- Issue
- 5
- Pages
- 324-336
- ISSN
- 0001-6349 (ISSN-L)
- 1600-0412
- OpenAlex
- W2040215162
- Cited by
- 31
- References
- 12
- FWCI
- 1.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Changing concepts of medical treatment of endometriosis. https://app.cochat.ai/papers/10.3109/00016349309021107
- The paper
- Kauppila, A. (1993). Changing concepts of medical treatment of endometriosis. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.3109/00016349309021107
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.